Agilent Technologies (A)

Common Stock
Sell: $128.00|Buy: $132.46|Change: 0.06 (-0.05%)

Open 

$130.32


Previous close 

$129.64


Trade high 

$131.425


Volume 

1,931,046


Year high 

$160.27


Year low 

$96.43


Dividend yield 

0.77%


Market capitalisation 

$36.74 bn


P/E ratio 

28.37


ISIN 

US00846U1016


Share price

Dividends

PreviousLatest
Record date30/09/202506/01/2026
Ex-dividend date30/09/202506/01/2026
Payment date22/10/202528/01/2026
Amount$0.248$0.255

Performance 06/02/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Agilent Technologies- 0.05
More...

Company profile

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest countryconcentrations.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.